The story of Viagra presents a challenging picture for investors. While the initial launch generated massive returns, the end of its exclusive rights opened the avenue to generic alternatives, dramatically eroding https://aoifejtkp540092.tblogz.com/sildenafil-and-pharma-a-volatile-opportunity-55010346